Vaishal Tolia
Emergency Medicine · San Diego, CANPI 1013198696
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,173 of the $2,520 with a category attached, or 86.2%. Roche Diagnostics Corporation accounts for 86.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $2,173 and has fallen 94.3% since, to $125 in 2023. Among emergency medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 5 payments — averaging $503.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$2K
- Irhythm Technologies, Inc.$231
- Konica Minolta Healthcare Americas, Inc$115
Across 36 payments — averaging $6742.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche Diagnostics Operations, Inc.$243K
What the payments were for
- Speaking & faculty fees$2,17386%
- Food & beverage$34714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 1 | $2,173 |
| Irhythm Technologies, Inc. | 3 | $231 |
| Konica Minolta Healthcare Americas, Inc | 1 | $115 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- cobas 6000 Core Unit$2,173
- ZIO XT Patch$106
How this compares
$2,520 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefpodoxime Proxetil | 38 | $1,825 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $182 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $133 |
| Ciprofloxacin Hcl | 16 | $75 |
| Cephalexin | 12 | $71 |
| Tizanidine Hcl | 11 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $49 |
| Amoxicillin | 19 | $46 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in San Diego
- Paul PearigenSan Diego$208K
- Christopher CoyneSan Diego$93K
- Bradley BaileySan Diego$35K
- Andrew DesjardinsSan Diego$35K
- Michael NielsenSan Diego$19K
- Michael BlueLone Pine$915K
- Andrew AccardiEncinitas$383K
- Fredrick Melik-AbrahamianSylmar$354K
- Graham WalkerStanford$309K
- Douglas WhiteOakland$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.